BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14726400)

  • 1. Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas.
    Grange F; Petrella T; Beylot-Barry M; Joly P; D'Incan M; Delaunay M; Machet L; Avril MF; Dalac S; Bernard P; Carlotti A; Esteve E; Vergier B; Dechelotte P; Cassagnau E; Courville P; Saiag P; Laroche L; Bagot M; Wechsler J
    Blood; 2004 May; 103(10):3662-8. PubMed ID: 14726400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
    Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
    Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study.
    Grange F; Bekkenk MW; Wechsler J; Meijer CJ; Cerroni L; Bernengo M; Bosq J; Hedelin G; Fink Puches R; van Vloten WA; Joly P; Bagot M; Willemze R
    J Clin Oncol; 2001 Aug; 19(16):3602-10. PubMed ID: 11504742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognosis of primary cutaneous lymphomas].
    Grange F; Bagot M
    Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):30-40. PubMed ID: 11937927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.
    Senff NJ; Hoefnagel JJ; Jansen PM; Vermeer MH; van Baarlen J; Blokx WA; Canninga-van Dijk MR; Geerts ML; Hebeda KM; Kluin PM; Lam KH; Meijer CJ; Willemze R
    J Clin Oncol; 2007 Apr; 25(12):1581-7. PubMed ID: 17353548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance.
    Hoefnagel JJ; Vermeer MH; Jansen PM; Fleuren GJ; Meijer CJ; Willemze R
    Br J Dermatol; 2003 Dec; 149(6):1183-91. PubMed ID: 14674895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cutaneous large B-cell lymphoma: the relation between morphology, clinical presentation, immunohistochemical markers, and survival.
    Fernández-Vázquez A; Rodríguez-Peralto JL; Martínez MA; Platón EM; Algara P; Camacho FI; López-Ríos F; Zarco C; Sánchez-Yus E; Fresno MF; Barthe L; Aliaga A; Fraga M; Forteza J; Oliva H; Piris MA
    Am J Surg Pathol; 2001 Mar; 25(3):307-15. PubMed ID: 11224600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous diffuse large B-cell lymphoma: prognostic significance of clinicopathological subtypes.
    Goodlad JR; Krajewski AS; Batstone PJ; McKay P; White JM; Benton EC; Kavanagh GM; Lucraft HH;
    Am J Surg Pathol; 2003 Dec; 27(12):1538-45. PubMed ID: 14657713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sézary syndrome. The French Study Group on Cutaneous Lymphomas.
    Grange F; Hedelin G; Joly P; Beylot-Barry M; D'Incan M; Delaunay M; Vaillant L; Avril MF; Bosq J; Wechsler J; Dalac S; Grosieux C; Franck N; Esteve E; Michel C; Bodemer C; Vergier B; Laroche L; Bagot M
    Blood; 1999 Jun; 93(11):3637-42. PubMed ID: 10339469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Fas and Fas ligand in cutaneous B-cell lymphomas.
    Zoi-Toli O; Meijer CJ; Oudejans JJ; de Vries E; van Beek P; Willemze R
    J Pathol; 1999 Dec; 189(4):533-8. PubMed ID: 10629554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary cutaneous B-cell lymphoma in Japanese patients.
    Liu Q; Ohshima K; Kikuchi M
    Pathol Int; 2000 Dec; 50(12):960-6. PubMed ID: 11123762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of survival in patients with primary cutaneous diffuse large B-cell lymphoma, leg type, in France.
    Grange F; Joly P; Barbe C; Bagot M; Dalle S; Ingen-Housz-Oro S; Maubec E; D'Incan M; Ram-Wolff C; Dalac S; Templier I; Esteve E; Quereux G; Machet L; Leduc M; Dereure O; Laroche L; Saiag P; Vergier B; Beylot-Barry M
    JAMA Dermatol; 2014 May; 150(5):535-41. PubMed ID: 24647650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous large B-cell lymphomas: relevance of the 2017 World Health Organization classification: clinicopathological and molecular analyses of 64 cases.
    Menguy S; Beylot-Barry M; Parrens M; Ledard AP; Frison E; Comoz F; Battistella M; Szablewski V; Balme B; Croue A; Franck F; Ortonne N; Tournier E; Lamant L; Carlotti A; De Muret A; Le Gall F; Lorton MH; Merlio JP; Vergier B
    Histopathology; 2019 Jun; 74(7):1067-1080. PubMed ID: 30715765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cutaneous medium and large cell lymphomas other than mycosis fungoides. An immunohistological and follow-up study on 54 cases. French Study Group for Cutaneous Lymphomas.
    Joly P; Vasseur E; Esteve E; Leibowitch M; Tilly H; Vaillant L; Wechsler J; Thomine E; De Muret A; Dreyfus F
    Br J Dermatol; 1995 Apr; 132(4):506-12. PubMed ID: 7748738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. bcl-2 protein expression in primary cutaneous large B-cell lymphoma is site-related.
    Geelen FA; Vermeer MH; Meijer CJ; Van der Putte SC; Kerkhof E; Kluin PM; Willemze R
    J Clin Oncol; 1998 Jun; 16(6):2080-5. PubMed ID: 9626207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary cutaneous B-cell lymphomas of the lower limbs: a study of integrin expression in 11 cases.
    Lair G; Parant E; Tessier MH; Jumbou O; Dreno B
    Acta Derm Venereol; 2000; 80(5):367-9. PubMed ID: 11200836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification.
    de Leval L; Harris NL; Longtine J; Ferry JA; Duncan LM
    Am J Surg Pathol; 2001 Jun; 25(6):732-41. PubMed ID: 11395550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the bcl-6 and MUM1/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: a tissue microarray study.
    Sundram U; Kim Y; Mraz-Gernhard S; Hoppe R; Natkunam Y; Kohler S
    J Cutan Pathol; 2005 Mar; 32(3):227-34. PubMed ID: 15701085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of bcl-6, CD10 and CD38 immunoreactivity in stage I-II gastric lymphomas: identification of a subset of CD10+ large B-cell lymphomas with a favorable outcome.
    Ponzoni M; Ferreri AJ; Pruneri G; Pozzi B; Dell'Oro S; Pigni A; Pinotti G; Villa E; Freschi M; Viale G; Capella C
    Int J Cancer; 2003 Aug; 106(2):288-91. PubMed ID: 12800208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Dutch Cutaneous Lymphoma Working Group.
    Vermeer MH; Geelen FA; van Haselen CW; van Voorst Vader PC; Geerts ML; van Vloten WA; Willemze R
    Arch Dermatol; 1996 Nov; 132(11):1304-8. PubMed ID: 8915307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.